de Faire U - Search Results

1

Associations of Polymorphisms in the Peroxisome Proliferator-Activated Receptor Gamma Coactivator-1 Alpha Gene With Subsequent Coronary Heart Disease: An Individual-Level Meta-Analysis.

Schillemans T, Tragante V, Maitusong B, Gigante B, Cresci S, Laguzzi F, Vikström M, Richards M, Pilbrow A, Cameron V, Foco L, Doughty RN, Kuukasjärvi P, Allayee H, Hartiala JA, Tang WHW, Lyytikäinen LP, Nikus K, Laurikka JO, Srinivasan S, Mordi IR, Trompet S, Kraaijeveld A, van Setten J, Gijsberts CM, Maitland-van der Zee AH, Saely CH, Gong Y, Johnson JA, Cooper-DeHoff RM, Pepine CJ, Casu G, Leiherer A, Drexel H, Horne BD, van der Laan SW, Marziliano N, Hazen SL, Sinisalo J, Kähönen M, Lehtimäki T, Lang CC, Burkhardt R, Scholz M, Jukema JW, Eriksson N, Åkerblom A, James S, Held C, Hagström E, Spertus JA, Algra A, de Faire U, Åkesson A, Asselbergs FW, Patel RS, Leander K. Schillemans T, et al. Among authors: de faire u. Front Physiol. 2022 Jun 23;13:909870. doi: 10.3389/fphys.2022.909870. eCollection 2022. Front Physiol. 2022. PMID: 35812313 Free PMC article.

2

PAI-1 level and the PAI-1 4G/5G polymorphism in relation to risk of non-fatal myocardial infarction: results from the Stockholm Heart Epidemiology Program (SHEEP).

Leander K, Wiman B, Hallqvist J, Sten-Linder M, de Faire U; Stockholm Heart Epidemiology Program. Leander K, et al. Among authors: de faire u. Thromb Haemost. 2003 Jun;89(6):1064-71. Thromb Haemost. 2003. PMID: 12783120

3

The complex between tPA and PAI-1: risk factor for myocardial infarction as studied in the SHEEP project.

Nordenhem A, Leander K, Hallqvist J, de Faire U, Sten-Linder M, Wiman B. Nordenhem A, et al. Among authors: de faire u. Thromb Res. 2005;116(3):223-32. doi: 10.1016/j.thromres.2004.12.007. Epub 2005 Jan 16. Thromb Res. 2005. PMID: 15935831

4

Primary risk factors influence risk of recurrent myocardial infarction/death from coronary heart disease: results from the Stockholm Heart Epidemiology Program (SHEEP).

Leander K, Wiman B, Hallqvist J, Andersson T, Ahlbom A, de Faire U. Leander K, et al. Among authors: de faire u. Eur J Cardiovasc Prev Rehabil. 2007 Aug;14(4):532-7. doi: 10.1097/HJR.0b013e328012e3cc. Eur J Cardiovasc Prev Rehabil. 2007. PMID: 17667644

5

Seven lipoprotein lipase gene polymorphisms, lipid fractions, and coronary disease: a HuGE association review and meta-analysis.

Sagoo GS, Tatt I, Salanti G, Butterworth AS, Sarwar N, van Maarle M, Jukema JW, Wiman B, Kastelein JJ, Bennet AM, de Faire U, Danesh J, Higgins JP. Sagoo GS, et al. Among authors: de faire u. Am J Epidemiol. 2008 Dec 1;168(11):1233-46. doi: 10.1093/aje/kwn235. Epub 2008 Oct 15. Am J Epidemiol. 2008. PMID: 18922999 Review.

6

Variants in the coagulation factor 2 receptor (F2R) gene influence the risk of myocardial infarction in men through an interaction with interleukin 6 serum levels.

Gigante B, Vikström M, Meuzelaar LS, Chernogubova E, Silveira A, Hooft FV, Hamsten A, de Faire U. Gigante B, et al. Among authors: de faire u. Thromb Haemost. 2009 May;101(5):943-53. Thromb Haemost. 2009. PMID: 19404549

7

The myeloperoxidase gene and its influence on myocardial infarction in a Swedish population: protective role of the -129A allele in women.

Zotova E, Lyrenäs L, de Faire U, Morgenstern R, Gigante B, Bennet AM. Zotova E, et al. Among authors: de faire u. Coron Artery Dis. 2009 Aug;20(5):322-6. doi: 10.1097/MCA.0b013e32832da06d. Coron Artery Dis. 2009. PMID: 19543083

8

Multi-organ expression profiling uncovers a gene module in coronary artery disease involving transendothelial migration of leukocytes and LIM domain binding 2: the Stockholm Atherosclerosis Gene Expression (STAGE) study.

Hägg S, Skogsberg J, Lundström J, Noori P, Nilsson R, Zhong H, Maleki S, Shang MM, Brinne B, Bradshaw M, Bajic VB, Samnegård A, Silveira A, Kaplan LM, Gigante B, Leander K, de Faire U, Rosfors S, Lockowandt U, Liska J, Konrad P, Takolander R, Franco-Cereceda A, Schadt EE, Ivert T, Hamsten A, Tegnér J, Björkegren J. Hägg S, et al. Among authors: de faire u. PLoS Genet. 2009 Dec;5(12):e1000754. doi: 10.1371/journal.pgen.1000754. Epub 2009 Dec 4. PLoS Genet. 2009. PMID: 19997623 Free PMC article.

9

Low levels of antibodies against phosphorylcholine predict development of stroke in a population-based study from northern Sweden.

Fiskesund R, Stegmayr B, Hallmans G, Vikström M, Weinehall L, de Faire U, Frostegård J. Fiskesund R, et al. Among authors: de faire u. Stroke. 2010 Apr;41(4):607-12. doi: 10.1161/STROKEAHA.109.558742. Epub 2010 Feb 11. Stroke. 2010. PMID: 20150554

10

Apolipoprotein C-I genotype and serum levels of triglycerides, C-reactive protein and coronary heart disease.

Olsson B, Gigante B, Mehlig K, Bergsten A, Leander K, de Faire U, Lissner L, Thelle DS, Carlsson LM. Olsson B, et al. Among authors: de faire u. Metabolism. 2010 Dec;59(12):1736-41. doi: 10.1016/j.metabol.2010.04.017. Epub 2010 Jul 2. Metabolism. 2010. PMID: 20580041

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

539 results

Search Page